Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

Key facts

Where
Shanghai, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06819202, who can take part

Where in China

  • Shanghai University of Traditional Chinese MedicineShanghai, ChinaContact: Sun YT Sun, PhD studentNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Sun Yuting
Trial code
NCT06819202
Record updated
14 May 2025
Original description
The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis.Read full original descriptionShow less

Effect of Hyperbaric Oxygen Therapy on Patients With Sudden Sensorineural Hearing Loss and Coagulation Function

The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis.

The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL.

The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared

Inclusion: Meet the diagnostic criteria for sudden deafness in the American Academy of Otolaryngology Head and Neck Surgery 2019 Clinical Practice Guidelines for Sudden Deafness; Aged 18-75 years old; Patients with unilateral sudden deafness for the first time, and the onset time is less than 2 weeks.

Exclusion: Patients with other ear diseases, such as auditory trauma, barotrauma, retrocochlear disease, bilateral hearing loss, history of chronic otitis media in the same ear, and history of surgery in the same ear; Patients with serious primary diseases such as heart, liver, kidney dysfunction and hematopoietic system diseases; Accompanied by serious mental illness; Pregnant and nursing patients; Patients with incomplete clinical data.

ClinicalTrials.gov NCT06819202